JP4486260B2 - 患者サンプルにおける止血機能不全の存在を予測するための方法および装置 - Google Patents

患者サンプルにおける止血機能不全の存在を予測するための方法および装置 Download PDF

Info

Publication number
JP4486260B2
JP4486260B2 JP2000597634A JP2000597634A JP4486260B2 JP 4486260 B2 JP4486260 B2 JP 4486260B2 JP 2000597634 A JP2000597634 A JP 2000597634A JP 2000597634 A JP2000597634 A JP 2000597634A JP 4486260 B2 JP4486260 B2 JP 4486260B2
Authority
JP
Japan
Prior art keywords
time
aptt
profile
dependent measurement
analyzer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2000597634A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002541431A (ja
JP2002541431A5 (US20040248308A1-20041209-M00001.png
Inventor
トー,チェン・ホック
ダウニー,コリン
フィッシャー,ティモシー・ジェイ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomerieux Inc
Original Assignee
Biomerieux Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomerieux Inc filed Critical Biomerieux Inc
Publication of JP2002541431A publication Critical patent/JP2002541431A/ja
Publication of JP2002541431A5 publication Critical patent/JP2002541431A5/ja
Application granted granted Critical
Publication of JP4486260B2 publication Critical patent/JP4486260B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/49Blood
    • G01N33/4905Determining clotting time of blood
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
JP2000597634A 1999-02-04 2000-02-04 患者サンプルにおける止血機能不全の存在を予測するための方法および装置 Expired - Fee Related JP4486260B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24434099A 1999-02-04 1999-02-04
US09/244,340 1999-02-04
PCT/US2000/002987 WO2000046603A1 (en) 1999-02-04 2000-02-04 A method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample

Publications (3)

Publication Number Publication Date
JP2002541431A JP2002541431A (ja) 2002-12-03
JP2002541431A5 JP2002541431A5 (US20040248308A1-20041209-M00001.png) 2007-03-29
JP4486260B2 true JP4486260B2 (ja) 2010-06-23

Family

ID=22922329

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000597634A Expired - Fee Related JP4486260B2 (ja) 1999-02-04 2000-02-04 患者サンプルにおける止血機能不全の存在を予測するための方法および装置

Country Status (9)

Country Link
US (1) US7211438B2 (US20040248308A1-20041209-M00001.png)
EP (1) EP1147423B1 (US20040248308A1-20041209-M00001.png)
JP (1) JP4486260B2 (US20040248308A1-20041209-M00001.png)
AT (1) ATE282208T1 (US20040248308A1-20041209-M00001.png)
AU (1) AU774889B2 (US20040248308A1-20041209-M00001.png)
CA (1) CA2362055C (US20040248308A1-20041209-M00001.png)
DE (1) DE60015726T2 (US20040248308A1-20041209-M00001.png)
ES (1) ES2231167T3 (US20040248308A1-20041209-M00001.png)
WO (1) WO2000046603A1 (US20040248308A1-20041209-M00001.png)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7732213B2 (en) * 1999-02-22 2010-06-08 Coramed Healthcare, Inc. Method of evaluating patient hemostasis
US6743596B1 (en) * 2000-10-27 2004-06-01 Biomerieux, Inc. Method of determining global coagulability hemostatic potential
WO2003073099A1 (en) 2002-02-27 2003-09-04 Biomerieux, Inc. Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome
MXPA05005071A (es) 2002-11-12 2005-07-22 Becton Dickinson Co Diagnostico de la sepsis o sirs usando perfiles de biomarcadores.
AU2003291483A1 (en) 2002-11-12 2004-06-03 Becton, Dickinson And Company Diagnosis of sepsis or sirs using biomarker profiles
EP1678649A2 (en) * 2003-10-21 2006-07-12 Philips Intellectual Property & Standards GmbH Method of automatically displaying medical measurement data
JP2008538007A (ja) 2005-04-15 2008-10-02 ベクトン,ディッキンソン アンド カンパニー 敗血症の診断
US7480593B2 (en) * 2005-08-03 2009-01-20 Suresh Gopalan Methods and systems for high confidence utilization of datasets
US8548935B2 (en) * 2008-02-14 2013-10-01 Orion Diagnostica Oy Predicting a future property using reagents by measuring properties at points in time
WO2009123737A2 (en) 2008-04-03 2009-10-08 Becton, Dickinson And Company Advanced detection of sepsis
WO2011159820A1 (en) * 2010-06-15 2011-12-22 Bayer Healthcare Llc Device
ES2755623T3 (es) 2012-05-07 2020-04-23 Lsi Medience Corp Procedimiento de detección de coagulación intravascular diseminada o coagulación intravascular diseminada infecciosa
US9597001B2 (en) * 2012-08-22 2017-03-21 Ben-Gurion University Of The Negev Research & Development Authority Separating clinically relevant sources of electrical activity in ECG signals
US10823743B1 (en) 2013-10-28 2020-11-03 Ifirst Medical Technologies, Inc. Methods of measuring coagulation of a biological sample
JP6430809B2 (ja) * 2014-12-19 2018-11-28 公立大学法人奈良県立医科大学 血液検体を判定するための方法、システム及びコンピュータプログラム、並びに血液検体分析装置
WO2018063914A1 (en) 2016-09-29 2018-04-05 Animantis, Llc Methods and apparatus for assessing immune system activity and therapeutic efficacy
US10971267B2 (en) 2017-05-15 2021-04-06 Medial Research Ltd. Systems and methods for aggregation of automatically generated laboratory test results
GB202004047D0 (en) 2020-03-20 2020-05-06 Ainger Phill Point of care sepsis assay device and method
EP4212880A1 (en) * 2020-09-08 2023-07-19 Sekisui Medical Co., Ltd. Blood coagulation reaction analysis method
JP2022062969A (ja) * 2020-10-09 2022-04-21 シスメックス株式会社 血液検体の分析方法、分析装置、および分析プログラム
CN116472354A (zh) * 2020-10-29 2023-07-21 积水医疗株式会社 凝血反应的检测方法
JPWO2022186381A1 (US20040248308A1-20041209-M00001.png) * 2021-03-05 2022-09-09

Family Cites Families (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1691741A (en) * 1928-11-13 Carrying bag and handle therefor
US177089A (en) * 1876-05-09 Improvement in bit-stocks
US590665A (en) * 1897-09-28 Machine
US1076086A (en) * 1910-10-21 1913-10-21 Charles C Vosburgh Window-furnishing.
US2070327A (en) * 1931-06-08 1937-02-09 Wood Newspaper Mach Corp Paper roll braking mechanism
US2005014A (en) * 1932-04-19 1935-06-18 Warner Brothers Pictures Inc Focusing device for a motion picture camera
US2012877A (en) * 1932-11-03 1935-08-27 Iwasa Morizo Hearing appliance
US2061953A (en) * 1936-02-12 1936-11-24 Sampson Max Toy aeroplane and control therefor
US2364453A (en) * 1939-09-13 1944-12-05 Standard Oil Co Processing hydrocarbon distillates
US2635081A (en) * 1950-12-13 1953-04-14 Sun Oil Co Molybdenum disulfide on a spent cracking catalyst
US3307392A (en) 1964-05-04 1967-03-07 Research Corp Automatic prothrombin timer apparatus and method
US3458287A (en) 1965-04-29 1969-07-29 Medical Laboratory Automation Method and means of determining endpoint times in blood clotting tests
US3502878A (en) * 1967-09-22 1970-03-24 Us Health Education & Welfare Automatic x-ray apparatus for limiting the field size of a projected x-ray beam in response to film size and to source-to-film distance
US3658480A (en) 1970-04-13 1972-04-25 Bio Data Corp Coagulation timing apparatus, and method
US4047890A (en) 1973-11-01 1977-09-13 Bio/Data Corporation Method and apparatus for determining deficiencies in enzymatic reactors particularly clotting factor levels in blood plasmas
SU590665A1 (ru) 1976-02-11 1978-01-30 Новосибирский государственный медицинский институт Способ исследовани процесса свертывани крови
US4040788A (en) 1976-04-05 1977-08-09 Sanford L. Simons Apparatus, instrumentation, and method for comparing samples
DE2635081C3 (de) 1976-08-04 1980-08-07 Bio/Data Corp., Willow Grove, Pa. (V.St.A.) Verfahren und Vorrichtung zur Bestimmung von Blutplasma-Gerinnungsfaktorpegeln
FR2364453A1 (fr) 1976-09-08 1978-04-07 Lacombe Pierre Dispositif electronique apportant un perfectionnement aux appareils destines a analyser la coagulation sanguine : prothrombinometre citrate-oxalate
US4199748A (en) 1976-11-01 1980-04-22 Rush-Presbyterian-St. Luke's Medical Center Automated method and apparatus for classification of cells with application to the diagnosis of anemia
JPS5451893A (en) 1977-09-30 1979-04-24 Sankyo Co Measuring of blood coagulating time
JPS5822703B2 (ja) 1978-08-30 1983-05-10 三共株式会社 血液凝固測定方法
US4254760A (en) * 1978-09-22 1981-03-10 Sirimarco Robert A Ceramic heat absorption panel
US4289498A (en) 1979-01-08 1981-09-15 Ortho Diagnostics, Inc. One-stage prothrombin assay and compositions useful therein
US4766083A (en) 1982-04-04 1988-08-23 Wako Pure Chemical Industries, Ltd. Method for the photometric determination of biological agglutination
SU1076086A1 (ru) 1982-12-28 1984-02-29 Всесоюзный Научно-Исследовательский И Конструкторский Институт Медицинской Лабораторной Техники Гемокоагулограф
US4705756A (en) 1983-01-26 1987-11-10 University Of Medicine And Dentistry Of New Jersey Method of determining the existence and/or the monitoring of a pathological condition in a mammal
EP0115459A3 (en) 1983-01-26 1986-11-20 University Of Medicine And Dentistry Of New Jersey Hematological prediction of sepsis and other disease states
JPS59203959A (ja) 1983-05-04 1984-11-19 Toa Medical Electronics Co Ltd 血液凝固時間測定装置
JPH0695095B2 (ja) 1983-11-25 1994-11-24 株式会社島津製作所 全自動血液分析装置
DE3502878A1 (de) 1985-01-29 1986-07-31 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur bestimmung des fibrinolytischen zustands von plasma
JPS61272655A (ja) 1985-05-28 1986-12-02 Iryo Kogaku Kenkyusho:Kk 血小板凝集能の定量的判定方法
GB8516081D0 (en) 1985-06-25 1985-07-31 Ciba Geigy Ag Assay & purification of amyloid components
US4902630A (en) 1985-07-22 1990-02-20 Abbott Laboratories Fluorescence polarization immunoassy and reagents for measurement of c-reactive protein
AU633488B2 (en) 1988-04-04 1993-02-04 Northwestern University Binding of immune complexes by modified forms of c-reactive protein
US5593897A (en) 1988-04-04 1997-01-14 Northwestern University Binding of immune complexes by modified forms of C-reactive protein
US4965725B1 (en) 1988-04-08 1996-05-07 Neuromedical Systems Inc Neural network based automated cytological specimen classification system and method
US5156974A (en) 1988-05-27 1992-10-20 Biodata Corporation Method for determining the fibrinogen level of a blood sample
US5003065A (en) 1988-06-14 1991-03-26 Carey Merritt Compounds and process for measuring c-reactive protein
US5697369A (en) 1988-12-22 1997-12-16 Biofield Corp. Method and apparatus for disease, injury and bodily condition screening or sensing
US5055412A (en) 1989-03-21 1991-10-08 Proksch Gary J Factor sensitive reagent for testing of blood coagulation containing ellagic acid and divalent metal ions and method of making the same
US5500345A (en) 1989-04-25 1996-03-19 Iatron Laboratories, Inc. Hybridomas producing monoclonal antibodies specific for C-reactive protein and methods for detection of C-reactive protein
WO1991000872A1 (en) 1989-06-27 1991-01-24 Rush-Presbyterian-St. Luke's Medical Centre Monoclonal antibodies to c-reactive protein
WO1991001383A1 (en) 1989-07-14 1991-02-07 Michigan State University Method for diagnosing blood clotting disorders
US5051357A (en) 1989-07-14 1991-09-24 Board Of Trustees Operating Michigan State University Method and assay using inactivation of factors Va and VIIIa by activated Protein C to diagnose thrombic disease or assay for Protein C and kit therefor
WO1991001497A1 (en) 1989-07-20 1991-02-07 Analytical Control Systems, Inc. Improved stable coagulation controls
SU1691741A1 (ru) 1989-08-25 1991-11-15 Донецкий государственный медицинский институт Способ прогнозировани геморрагических осложнений при травматической болезни
US4998535A (en) 1989-09-05 1991-03-12 Univ. of Washington New England Medical Center Hospitals, Inc. Thrombolysis predictive instrument
US5262303A (en) 1989-10-13 1993-11-16 Trustees Of Boston University Ligand/anti-ligand assays for adherent proteins
US5646046A (en) 1989-12-01 1997-07-08 Akzo Nobel N.V. Method and instrument for automatically performing analysis relating to thrombosis and hemostasis
IE904244A1 (en) 1989-12-01 1991-06-05 Akzo Nv Direct fibrinogen assay
US5169786A (en) 1989-12-19 1992-12-08 Ortho Diagnostic Systems, Inc. Method of determining levels of extrinsic and intrinsic clotting factors and protein c
ATE140034T1 (de) 1990-04-17 1996-07-15 Analytical Control Syst Inc Koagulationsassays und reagenzien
US5862304A (en) 1990-05-21 1999-01-19 Board Of Regents, The University Of Texas System Method for predicting the future occurrence of clinically occult or non-existent medical conditions
US5218529A (en) 1990-07-30 1993-06-08 University Of Georgia Research Foundation, Inc. Neural network system and methods for analysis of organic materials and structures using spectral data
JPH04254760A (ja) 1991-01-30 1992-09-10 Eiken Chem Co Ltd 血清アミロイドa標準物質、およびその設定方法
US5221628A (en) 1991-03-19 1993-06-22 Northwestern University Binding of aggregated immunoglobulin or immune complexes by serum amyloid P component
RU2012877C1 (ru) 1991-04-01 1994-05-15 Белорусский научно-исследовательский институт охраны материнства и детства Способ прогнозирования синдрома дыхательных расстройств у недоношенных новорожденных
US5180835A (en) * 1991-06-25 1993-01-19 American Cyanamid Company Process for the preparation of monomeric tetramethoxymethylglycoloril
EP0525273B1 (en) 1991-08-02 1996-10-16 Grupo Grifols, S.A. Process and apparatus for the determination of the coagulation time of blood and plasma
US5716795A (en) 1991-10-04 1998-02-10 Matschiner; John T. Thrombomodulin-based coagulometric assay of the protein C system
AU2870992A (en) 1991-10-04 1993-05-03 Board Of Regents Of The University Of Nebraska, The A soluble thrombomodulin-based one-stage assay for vitamin k-dependent coagulation-inhibiting proteins
EP0642667B1 (en) 1991-11-04 2001-01-10 Adeza Biomedical Corporation Screening method for identifying women at increased risk for preterm delivery
JPH05180835A (ja) 1991-12-27 1993-07-23 S R L:Kk ループスアンチコアグラントの測定方法
US5318958A (en) 1992-05-29 1994-06-07 Queen's University At Kingston Amyloid precursor protein
JP2934557B2 (ja) 1992-07-10 1999-08-16 国際試薬株式会社 血液凝固時間測定方法とその装置
JPH0636061A (ja) 1992-07-21 1994-02-10 Fujitsu Ltd 階層型ニューラルネットワークの学習方式
US5388164A (en) 1992-08-19 1995-02-07 Olympus Optical Co., Ltd. Method for judging particle agglutination patterns using neural networks
JP3224607B2 (ja) 1992-09-11 2001-11-05 株式会社アズウェル 血液凝固第xiii因子活性測定方法および該測定用試薬キット
US5369484A (en) 1992-11-09 1994-11-29 Akzo N.V. Multiple discrete analyzer test apparatus and method
US5358852A (en) 1992-12-21 1994-10-25 Eastman Kodak Company Use of calcium in immunoassay for measurement of C-reactive protein
RU2070327C1 (ru) 1992-12-25 1996-12-10 Безруков Александр Васильевич Устройство для измерения времени свертывания крови
US5344754A (en) 1993-01-13 1994-09-06 Avocet Medical, Inc. Assay timed by electrical resistance change and test strip
JP2938302B2 (ja) 1993-02-25 1999-08-23 国際試薬株式会社 血液凝固時間測定方法とその装置
JPH06249857A (ja) 1993-02-26 1994-09-09 Hitachi Ltd 自動分析装置
RU2061953C1 (ru) 1993-03-10 1996-06-10 Тюменский государственный медицинский институт МЗ РФ Способ количественного определения общей коагуляционной активности тромбоцитов
US5670329A (en) 1993-05-28 1997-09-23 Cardiovascular Diagnostics, Inc. Method and analytical system for performing fibrinogen assays accurately, rapidly and simply using a rotating magnetic field
DK0633473T3 (da) 1993-06-30 1999-08-09 Stiftung F R Diagnostische For Måling af den aktiverede partielle thromboplastin-tid (APTT) i en reaktion i et enkelt trin
AU688365B2 (en) 1993-08-16 1998-03-12 Biomerieux, Inc. Method and instrument for automatically performing analysis relating to thrombosis and hemostasis
US5526111A (en) 1993-08-31 1996-06-11 Boehringer Mannheim Corporation Method and apparatus for calculating a coagulation characteristic of a sample of blood a blood fraction or a control
US5472852A (en) 1993-09-15 1995-12-05 Oklahoma Medical Research Foundation Assay for detection of selective Protein C inhibition by patients
US5473732A (en) 1993-11-02 1995-12-05 Chang; Hou-Mei H. Relational artificial intelligence system
US5553616A (en) 1993-11-30 1996-09-10 Florida Institute Of Technology Determination of concentrations of biological substances using raman spectroscopy and artificial neural network discriminator
US5856114A (en) 1994-03-21 1999-01-05 The University Of Vermont Immunologic detection of factor VA fragments in hemorrhagic and thrombotic clinical settings
ES2160708T3 (es) 1994-04-28 2001-11-16 Dade Behring Inc Calibrador para ensayos de tiempo de protrombina (tp).
AU1287595A (en) 1994-08-26 1996-03-22 Immtech International, Inc. A mutant protein and methods and materials for making and using it
US5504011A (en) 1994-10-21 1996-04-02 International Technidyne Corporation Portable test apparatus and associated method of performing a blood coagulation test
SE9403833D0 (sv) 1994-11-08 1994-11-08 Global Hemostasis Inst Mgr Ab Analysförfarande och kit
US5705395A (en) 1994-11-14 1998-01-06 The Scripps Research Institute Method for diagnosis of thrombotic disorders
US5567596A (en) 1994-12-29 1996-10-22 Research Foundation Of State University Of New York Rapid assay of activators and inhibitors of clotting
WO1996021740A1 (en) 1995-01-10 1996-07-18 Hendrik Coenraad Hemker Methods of determining endogenous thrombin potential (etp) and thrombin substrates for use in said methods
US5708591A (en) * 1995-02-14 1998-01-13 Akzo Nobel N.V. Method and apparatus for predicting the presence of congenital and acquired imbalances and therapeutic conditions
US6321164B1 (en) * 1995-06-07 2001-11-20 Akzo Nobel N.V. Method and apparatus for predicting the presence of an abnormal level of one or more proteins in the clotting cascade
US6898532B1 (en) * 1995-06-07 2005-05-24 Biomerieux, Inc. Method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
US6429017B1 (en) * 1999-02-04 2002-08-06 Biomerieux Method for predicting the presence of haemostatic dysfunction in a patient sample
US5780255A (en) 1995-06-09 1998-07-14 Instrumentation Laboratory, S.P.A. Protein C pathway screening test
DE69607176T2 (de) 1995-07-21 2000-09-21 Trinity College Dublin Verfahren zur quantitativen bestimmung menschlichen akutphasen-serum-amyloid-a-proteins; rekombinantes protein; spezifischer antikörper
US5766869A (en) 1995-11-30 1998-06-16 Ahs Hospital Corp. Factor V ratio blood test for susceptibility to thromboembolism
EP0827425B1 (en) 1996-03-22 2004-11-03 Dade Behring Inc. Combination reagent holding and test device
JPH1026621A (ja) 1996-07-12 1998-01-27 Dai Ichi Pure Chem Co Ltd イムノアッセイ法
JP3876022B2 (ja) 1996-09-26 2007-01-31 生化学工業株式会社 血液凝固時間に影響を与える物質の定量方法
EP0841566A1 (en) 1996-11-11 1998-05-13 Pentapharm A.G. Positive control plasma for lupus anticoagulant
ATE530180T1 (de) 1997-04-02 2011-11-15 Brigham & Womens Hospital Verfahren zur ermittlung der individualen risikoprofile atherosklerotischen erkrankungen
US6010911A (en) 1997-04-30 2000-01-04 Medtronic, Inc. Apparatus for performing a heparin-independent high sensitivity platelet function evaluation technique
US6027115A (en) * 1998-03-25 2000-02-22 International Game Technology Slot machine reels having luminescent display elements
US6249855B1 (en) * 1998-06-02 2001-06-19 Compaq Computer Corporation Arbiter system for central processing unit having dual dominoed encoders for four instruction issue per machine cycle
CN1309770A (zh) 1998-07-31 2001-08-22 华莱士·E·卡罗尔 确定抗凝治疗因子的设备和方法

Also Published As

Publication number Publication date
CA2362055C (en) 2010-07-20
US7211438B2 (en) 2007-05-01
EP1147423B1 (en) 2004-11-10
CA2362055A1 (en) 2000-08-10
DE60015726D1 (de) 2004-12-16
JP2002541431A (ja) 2002-12-03
EP1147423A4 (en) 2002-04-17
ES2231167T3 (es) 2005-05-16
AU774889B2 (en) 2004-07-08
US20040248308A1 (en) 2004-12-09
AU3483300A (en) 2000-08-25
WO2000046603A1 (en) 2000-08-10
DE60015726T2 (de) 2005-12-22
EP1147423A1 (en) 2001-10-24
ATE282208T1 (de) 2004-11-15

Similar Documents

Publication Publication Date Title
JP4486260B2 (ja) 患者サンプルにおける止血機能不全の存在を予測するための方法および装置
CA2316361C (en) A method for predicting an abnormal level of clotting proteins
EP0834145B1 (en) A method and apparatus for predicting the presence of congenital and acquired imbalances and therapeutic conditions
Vogel et al. Admission rapid thrombelastography delivers real-time “actionable” data in pediatric trauma
CA3006390A1 (en) Mr-proadm as marker for the extracellular volume status of a subject
US6898532B1 (en) Method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
AU6617900A (en) A method for predicting the presence of haemostatic dysfunction in a patient sample
WO2006049300A1 (ja) 血小板血栓症又は臓器障害の検出方法
US20210215726A1 (en) Method for assaying d-dimers specific to venous thromboembolism and use thereof for diagnosing pulmonary embolism and deep venous thrombosis
Takayama et al. Dielectric blood coagulometry for the early detection of sepsis-induced disseminated intravascular coagulation: a prospective observational study
EP1522860A1 (en) A method and apparatus for predicting the presence of haemostatic dysfunction in a patient sample
RU2217754C1 (ru) Способ прогнозирования клинического течения ишемического инсульта
Givens et al. Predicting the presence of plasma heparin using neural networks to analyze coagulation screening assay optical profiles
Liu et al. Objective: In the present study, we investigated the associations between D-dimer levels at admission and early adverse events in patients with acute type A aortic dissection undergoing arch replacement and the frozen elephant trunk (FET).

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20050513

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20050513

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070205

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070205

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20090807

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090814

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20091116

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20091124

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20091214

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20091221

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100114

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20100226

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20100326

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20130402

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140402

Year of fee payment: 4

LAPS Cancellation because of no payment of annual fees